Clinical trials - Press Releases

Date	Title	Company
15-Mar-2021	Beckman Coulter’s Interleukin-6 test is now available for use in helping identify severe inflammatory response in COVID-19 patients	Beckman Coulter
15-Mar-2021	bluebird bio Presents Long-Term Data for elivaldogene autotemcel (eli-cel, Lenti-D™) Gene Therapy for Cerebral Adrenoleukodystrophy (CALD)	bluebird bio
15-Mar-2021	Phase 3 trial of Libtayo® (cemiplimab) monotherapy in advanced cervical cancer stopped early for positive result on overall survival	Sanofi
12-Mar-2021	Cytel’s East Bayes® Broadens & Simplifies Access to Complex Bayesian Clinical Trial Designs	Cytel Inc.
12-Mar-2021	Kintor Pharmaceutical Announces Results from Investigator-Initiated Brazil Trial Demonstrating 92% Reduction in Mortality in Hospitalized COVID-19 Patients	Kintor Pharmaceutical
12-Mar-2021	CluePoints Sponsors RBQM Live - The Definitive Guide to RBQM for Experts and Beginners	CluePoints
12-Mar-2021	Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers	Xperiome
12-Mar-2021	Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate	Sanofi
12-Mar-2021	Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials	Novavax
12-Mar-2021	CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers	CD Bioparticles
11-Mar-2021	GSK expands its clinical trial manufacturing capacity for cell and gene therapy at the Cell and Gene Therapy Catapult facility in Stevenage	Cell and Gene Therapy Catapult
11-Mar-2021	Global Clinical Perinatal Software market was valued at USD 424.84 million in 2020 and is expected to grow at a CAGR of 8.02%.	Introspective Market Research
11-Mar-2021	Pulmocide announces publication of clinical data in two peer-reviewed publications highlighting potential of PC945, a novel inhaled antifungal drug candidate, in lung infections	Pulmocide
11-Mar-2021	Kite, a Gilead Company, to share latest scientific advances in cell therapy research at the 47th Virtual Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)	Kite, a Gilead Company
11-Mar-2021	Roche provides update on the phase III REMDACTA trial of Actemra/RoActemra plus Veklury in patients with severe COVID-19 pneumonia	Roche
11-Mar-2021	Lilly's bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19	Lilly
11-Mar-2021	Transgene expands Phase II clinical trial of therapeutic vaccine TG4001 in combination with avelumab versus avelumab monotherapy in patients with HPV16-positive anogenital cancers	Transgene
11-Mar-2021	GSK expands its clinical trial manufacturing capacity for cell and gene therapy at the Cell and Gene Therapy Catapult facility in Stevenage	GSK
10-Mar-2021	Lynne Ensor, Parexel Chair of SMi’s 4th Annual Pharmaceutical Microbiology East Coast Conference, exclusive interview released	SMi Group
09-Mar-2021	Merck Presents Results from Phase 1 Trial Evaluating Investigational Islatravir Subdermal Implant for the Prevention of HIV-1 Infection at CROI 2021	Merck